We envision a future where medical professionals and their patients have the best tools and information to simply and effectively assess and manage liver health
To stay up-to-date on the latest trends and news in non-invasive chronic liver disease management, follow us on @Echosens global page. ๐ #liverhealthmatters
https://t.co/H4VAXAysiV
Are you aware of the relationship between #NAFLD, an asymptomatic condition characterized by elevated levels of fat in the liver, and #diabetes?
Find out why #T2DM patients should be monitored for #NAFLD.
https://t.co/p2MqzzqJSt
New recommendations from the USPSTF recommend screening for #HBV infection in adolescents and adults at increased risk for infection.
Learn more:
https://t.co/uvQl1LTCBY
Join echosens in our next educational webinar as we welcome physician expert Dr. Caroline Apovian, the Director of Nutrition and Weight Management at Boston Medical Center.
Click for details!
https://t.co/gPnk7mOTlO
The silent liver diseases you need to know about, #NAFLD and #NASH. Affecting the livers of more than 100 million Americans, NAFLD and NASH can lead to cirrhosis of the #liver and liver cancer.
Get the facts so you can prevent these diseases:
https://t.co/xgu5CzOqhK
Fatty liver disease is a chronic liver disease and a rapidly growing problem. Find out how Dr. Richard Gilroy of Intermountain Healthcare's liver transplantation program is addressing this problem.
https://t.co/ZfndYrZXg7
#liverhealthmatters#NAFLD
A recent study unveiled that #FibroScan was highly effective at non-invasively assessing liver fibrosis in #alcoholic patients and that instant screening of liver fibrosis in heavy drinkers is feasible without a liver biopsy.
Learn more: https://t.co/RsOYTzs6we
From all of us at Echosens, a special thank you to all the doctors and healthcare professionals for everything they are doing to fight #COVID19. #healthcareheroes
Worldwide, 292M people are chronically infected with chronic hepatitis B. Find out the impact #NASH has on these individuals in the latest webinar from Dr. Robert Gish, the Medical Director of The Hepatitis B Foundation.
Register Today:
https://t.co/ecR1E8E6mk
Discover new innovative tools that support diagnosis efficiency, improve accuracy and reduce costs in the battle against #liverdisease.
https://t.co/RqfrVTcUJx
#liverhealthmatters
Join Echosens as we welcome Dr. Robert Gish, the Medical Director for the Hepatitis B Foundation, as he presents new findings on the intersection of #HBV, #NASH and #T2DM.
Learn More:
https://t.co/SFvSCWdY33
Echosens proudly announces its collaboration with MetaPhy Health to support turn-key, comprehensive #chronicliverdisease management services to #gastroenterology practices for their patients with #fattyliverdisease.
Learn More: https://t.co/1G9muuWlY8
Echosens has arranged an independent assessment conducted by Santa Barbara Actuaries, a healthcare consulting firm specializing in predictive modeling and analytics, to determine the cost savings of #FibroScan care models at the #pointofcare.
Learn More:
https://t.co/rZxevUvzz2